Inventor · disambiguated record
Kirk L. Stevens
Also filed as: STEVENS KIRK · STEVENS KIRK L · STEVENS KIRK LAWRENCE
25 granted patents·13 pending applications·138 citations·filing 2001–2025
95Inventor score
Top patents by PatentIndex Score
38 records- 0197US11905299B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 20, 2024·3 cites·3 claims
- 0296US11066414B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Granted Jul 20, 2021·10 cites·9 claims
- 0395US9878995B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jan 30, 2018·14 cites·16 claims
- 0494US11224600B2Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Jan 18, 2022·9 cites·21 claims
- 0592US10316017B2COT modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 11, 2019·12 cites·30 claims
- 0692US9815818B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Granted Nov 14, 2017·13 cites·32 claims
- 0791US9765060B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Sep 19, 2017·13 cites·2 claims
- 0891US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 0989US11179383B2Compounds for inhibition of α4β7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·3 cites·20 claims
- 1085US2025346609A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1185US2024254137A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1283US11174256B2Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 16, 2021·2 cites·18 claims
- 1383US11116760B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2019·Granted Sep 14, 2021·3 cites·23 claims
- 1483US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 1583US7812022B22-pyrimidinyl pyrazolopyridine ErbB kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2005·Granted Oct 12, 2010·8 cites·15 claims
- 1679US11578069B2Compounds for inhibition of α4 β7 integrinGILEAD SCIENCES INC·Filed 2020·Granted Feb 14, 2023·1 cites·11 claims
- 1777US7166597B2Fused pyrazole derivatives being protein kinase inhibitorsGLAXO GROUP LTD·Filed 2001·Granted Jan 23, 2007·13 cites·13 claims
- 1877US2025032473A1Quinoline derivativesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1976US10221197B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 5, 2019·2 cites·13 claims
- 2076US7981903B22-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancerGLAXOSMITHKLINE LLC·Filed 2008·Granted Jul 19, 2011·4 cites·17 claims
- 2170US8093239B2Imidazopyridine kinase inhibitorsKUNTZ KEVIN·Filed 2008·Granted Jan 10, 2012·2 cites·37 claims
- 2269US7279473B2Pyrazolopyridazine derivativesSMITHKLINE BEECHAM CORP·Filed 2002·Granted Oct 9, 2007·5 cites·36 claims
- 2369US2019248807A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 2468US12053462B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2021·Granted Aug 6, 2024·0 cites·18 claims
- 2566US2018237455A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2665US2022226337A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2765US2022152014A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2864US12410160B2KHK inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Sep 9, 2025·0 cites·38 claims
- 2963US2022135561A1Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 3061US2017008905A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3158US9617310B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2014·Granted Apr 11, 2017·0 cites·4 claims
- 3248US2018065953A1Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 3347US2013012504A1Bi-functional quinoline analogsGILEAD SCIENCES INC·Filed 2012·Application pending·0 cites
- 3447US2017313745A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 3546US8367829B2Bi-functional pyrazolopyridine compoundsGILEAD SCIENCES INC·Filed 2011·Granted Feb 5, 2013·0 cites·18 claims
- 3643US8450490B2Bi-functional pyrazolopyridine compoundsBAKER WILLIAM R·Filed 2012·Granted May 28, 2013·0 cites·4 claims
- 3740US11021467B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Jun 1, 2021·0 cites·17 claims
- 3840US2006205740A1Chemical compoundsRENO MICHAEL J·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kirk L. Stevens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →